Physician profile
Philip E Holmes
NPI 1801905518
$586.33
in general payments reported to CMS, 2019-2025
9 companies · $29.88 in 2025
The $29.88 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.51 · 2020: $28.32 · 2021: $200 · 2022: $111 · 2023: $78.60 · 2024: $77.85 · 2025: $29.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $186.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $270.57 | 2020-2024 | Actishield, Spy-Phi System |
| Osteomed LLC | $113.20 | 2021 | |
| Smith+Nephew, INC. | $48.74 | 2019 | |
| Organogenesis INC. | $38.18 | 2022 | |
| Convatec INC. | $29.88 | 2025 | |
| Biotissue Holdings INC. | $26.22 | 2024 | |
| Ets Wound Care LLC | $25.43 | 2024 | Mirragen Advanced Wound Matrix |
| Heron Therapeutics, INC. | $22.34 | 2023 | Zynrelef |
| Biocomposites INC | $11.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Holmes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.